MARCH 9, 2018 By Patricia Feijo

Summary: Guidelines now being proposed by the FDA would restrict the public’s access to Homeopathic remedies, benefitting BIG PHARMA, but harming Americans who should continue to have unregulated access to these healing products. Federal law does not give the FDA the authority to apply the rules designed only for toxic pharmaceuticals to nontoxic Homeopathic remedies. The FDA’s only job is to ensure that products are manufactured according to legal standards and are properly labeled. The rules and regulations governing Homeopathic remedies that have been in place for most of the last century are more than adequate to protect the public.

Late last year, the FDA proposed new guidelines for Drug Products Labeled as Homeopathic (Draft Guidance Dec. 2017), disregarding federal law and usurping the right of American people to use historically available health-enhancing products of their choosing. Rather than promote the public welfare, these guidelines, if implemented, will injure countless individuals and the nation’s health. At the end of this article, I delineate the specific threats posed by these proposed guidelines and explain how greater regulation would place unnecessary restrictions on safe and beneficial Homeopathic products. Lastly, I explain how to file comments on-line with the FDA, where comments are due by March 20, 2018.

If you don’t have the time to read this entire article, but you understand the importance of continued access to Homeopathic Remedies — please go right to the end of this article and file your comments with the FDA.

The FDA is claiming that it is Homeopathy’s rise in popularity that has forced it to focus attention on Homeopathy, and to take a fresh look at restricting access to Homeopathic remedies and products. Is that a good enough reason to clamp down on Homeopathy? While there have been charges made about the safety of a few Homeopathic products (e.g., Belladonna and Homeopathic teething tablets), these charges have been shown to be baseless, and can usually be tracked back to Big Pharma and its minions. Absolutely no evidence has been presented that any of these charges against these products are true, and significant proof should be demanded before such charges are believed and acted upon. The few specific complaints the FDA points to must be carefully analyzed for other causative factors. Some of those could include whether the babies that reportedly developed seizures had recently been vaccinated, or were given other drug products, or were nursing mothers taking dangerous, but FDA-approved, pharmaceutical drugs.